Replies to post #1959 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

Yes, HBV is now the lead program, for all practical purposes. RSV is ready to roll—as soon as the virus makes a re-appearance, which might not be for another six months or so. NASH has been relegated to an afterthought.